Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy
Open Access
Abstract
As one of the most common cancers worldwide, non-small-cell lung cancer (NSCLC) treatment always fails owing to the tumor microenvironment and resistance. UA, a traditional Chinese medicine, was reported to have antitumor potential in tumor models in vitro and in vivo, but showed impressive results in its potential application for poor water solubility. In this study, a novel biomimetic drug-delivery system based on UA-loaded nanoparticles (UaNPs) with a red blood cell membrane (RBCM) coating was developed. The RBCM-coated UANPs (UMNPs) exhibited improved water solubility, high stability, good biosafety, and efficient tumor accumulation. Importantly, the excellent antitumor efficiency of the UMNPs was confirmed both in vitro and in vivo in cancer models. In addition, we further investigated the antitumor mechanism of UMNPs. The results of Western blotting showed that UMNPs exerted an anticancer effect by inducing the apoptosis and autophagy of NSCLC cells, which makes it superior to free UA. In addition, body weight monitoring, hematoxylin and eosin (HE) analysis, and immunohistochemical (IHC) analysis showed no significant difference between UMNPs and the control group, indicating the safety of UMNPs. Altogether, the preparation of biomimetic UMNPs provides a promising strategy to improve outcomes in NSCLC.Keywords
Funding Information
- National Natural Science Foundation of China (81773211, 82073308, KY109RC2019010)
- High-level startup fund of Nanjing Medical University (81773211, 82073308, KY109RC2019010)
This publication has 40 references indexed in Scilit:
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapySeminars in Cancer Biology, 2018
- Characteristics, Properties and Analytical Methods of Paclitaxel: A ReviewCritical Reviews in Analytical Chemistry, 2018
- Supramolecular Nanofibers of Curcumin for Highly Amplified Radiosensitization of Colorectal Cancers to Ionizing RadiationAdvanced Functional Materials, 2018
- Red Blood Cells as Smart Delivery SystemsBioconjugate Chemistry, 2018
- Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistanceCancer Science, 2017
- Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric DiseasesCNS Drugs, 2017
- Ursolic acid, a potential anticancer compound for breast cancer therapyCritical Reviews in Food Science and Nutrition, 2017
- Ursolic acid (UA): A metabolite with promising therapeutic potentialLife Sciences, 2016
- Non-small-cell lung cancers: a heterogeneous set of diseasesNature Reviews Cancer, 2014
- PLGA-based nanoparticles: An overview of biomedical applicationsJournal of Controlled Release, 2012